Status:
UNKNOWN
Inert Gas Rebreathing in Ventilated Patients
Lead Sponsor:
Universitätsmedizin Mannheim
Conditions:
Sepsis
Respiratory Failure
Eligibility:
All Genders
18-80 years
Brief Summary
Measuring hemodynamic parameters in ventilated patients is important yet still complicated to perform. Inert gas rebreathing (IGR) showed promising results when being compared to other invasive as wel...
Eligibility Criteria
Inclusion
- age 18 - 80 years
- mechanically ventilated patient
- existing PiCCO arterial line
Exclusion
- FiO2 \> 60% (fraction of inspired oxygen)
- PEEP \> 10 mmHg (positive end-expiratory pressure)
- SO2 \< 90% (oxygen saturation )
- Systolic blood pressure \< 90 mmHg
- Heart rate \> 150 bpm
- APRV (airway pressure release ventilation)
- ICD (implantable cardioverter defibrillator) / pace maker
- \[ Anaesthetic Conserving Device (Anaconda) \]
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01891253
Start Date
March 1 2013
End Date
December 1 2020
Last Update
September 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsmedizin Mannheim
Manheim, Baden-Wurttemberg, Germany, 68167